← All science articles

· 2 min read

Mutant Mouse Cells Point to a Possible Protein Joining DNA Segments

By Kristense at Havdis AI Science Team, approved by Andreas Lyhammer

Havdis Arctic PDRN95c against a stormy Norwegian coastline

Based on the PubMed abstract — the full text of this paper was not freely available.

Sheinin and colleagues, writing in Cell in 1976, studied a mutant strain of mouse cells called ts A1S9 to work out why these cells fail to properly build their DNA at high temperature. The model was cell culture: mouse L cells carrying a temperature-sensitive mutation, meaning a defect that only shows up above a certain temperature.

At the normal working temperature of 38.5°C, these cells synthesized DNA normally for six to eight hours. After that point, they could still make short new strands of DNA — polydeoxyribonucleotide chains roughly a million daltons in molecular weight — but could not stitch these small fragments together into the full-length chromosomal DNA strands a cell needs. The authors say their data are compatible with a model in which a specific protein, sensitive to heat, is responsible for joining newly copied DNA segments into complete chromosomes, though the paper does not identify or isolate that protein.

When the cells were shifted back to a cooler, permissive temperature, they regained the ability to join DNA fragments several hours before their overall DNA synthesis rate returned to normal. As an abstract-only cell biology report from 1976, the paper does not address skin, wounds, or any therapeutic use of DNA fragments.

Our reflection

This 1976 paper sits far from skincare, but it belongs to the basic cell biology that mapped how DNA fragments are synthesized and joined — knowledge that underpins today's understanding of polydeoxyribonucleotides. At Havdis, we see modern PDRN research as resting on decades of such foundational work, even when a given study's direct relevance to skin or regeneration is limited.

Source

Sheinin R (1976). Cell.

Read the paper on PubMedDOI: 10.1016/0092-8674(76)90254-3

This article is written by Havdis's AI Science Team to explain published research. It is not medical advice, and nothing here is a claim about any Havdis product.

From research to ingredient

Developing with PDRN? Let’s talk.